Naxitamab (Anti-GD2)
Naxitamab (Anti-GD2) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers. MW: 145.5 KD.
| Trivial name | Naxitamab-gqgk; Humanized 3F8; Hu3F8 |
| Catalog Number | A2486 |
| CAS# | 1879925-92-4 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/naxitamab-anti-gd2.html |